- Home
- FSUN vs ATRC Comparison
FSUN vs ATRC Comparison
Compare FSUN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSUN
- ATRC
- Stock Information
- Founded
- FSUN 1892
- ATRC 2000
- Country
- FSUN United States
- ATRC United States
- Employees
- FSUN N/A
- ATRC N/A
- Industry
- FSUN Major Banks
- ATRC Medical/Dental Instruments
- Sector
- FSUN Finance
- ATRC Health Care
- Exchange
- FSUN Nasdaq
- ATRC Nasdaq
- Market Cap
- FSUN 1.1B
- ATRC 1.1B
- IPO Year
- FSUN N/A
- ATRC 2005
- Fundamental
- Price
- FSUN $40.03
- ATRC $30.72
- Analyst Decision
- FSUN Hold
- ATRC Strong Buy
- Analyst Count
- FSUN 1
- ATRC 9
- Target Price
- FSUN N/A
- ATRC $41.78
- AVG Volume (30 Days)
- FSUN 99.2K
- ATRC 412.3K
- Earning Date
- FSUN 01-01-0001
- ATRC 02-13-2025
- Dividend Yield
- FSUN N/A
- ATRC N/A
- EPS Growth
- FSUN N/A
- ATRC N/A
- EPS
- FSUN 3.05
- ATRC N/A
- Revenue
- FSUN $348,035,000.00
- ATRC $447,573,000.00
- Revenue This Year
- FSUN N/A
- ATRC $17.75
- Revenue Next Year
- FSUN $80.04
- ATRC $13.44
- P/E Ratio
- FSUN $13.11
- ATRC N/A
- Revenue Growth
- FSUN N/A
- ATRC 17.56
- 52 Week Low
- FSUN $33.00
- ATRC $18.94
- 52 Week High
- FSUN $44.37
- ATRC $39.05
- Technical
- Relative Strength Index (RSI)
- FSUN 52.59
- ATRC 34.24
- Support Level
- FSUN $37.15
- ATRC $31.23
- Resistance Level
- FSUN $40.80
- ATRC $32.16
- Average True Range (ATR)
- FSUN 2.53
- ATRC 1.23
- MACD
- FSUN -0.22
- ATRC -0.61
- Stochastic Oscillator
- FSUN 40.22
- ATRC 15.51
About FSUN FirstSun Capital Bancorp
Firstsun Capital Bancorp is the financial holding company for Sunflower Bank, National Association. It provides a full range of deposit, lending, treasury management, wealth management and online banking products and services. The company operates in two segments - Banking operations and Mortgage operations, out of which the majority of the revenue is generated from the Banking operations segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.